IQV— IQVIA HOLDINGS INC.

IndustrialsLife Sciences Tools & Services$39.8B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenues	$16.31B+5.9%	$15.40B+2.8%	$14.98B+4.0%	$14.41B
Cost of revenues, exclusive of depreciation and amortization	$10.88B+8.5%	$10.03B+2.9%	$9.74B+3.9%	$9.38B
Selling, general and administrative expenses	$2.00B+0.4%	$1.99B-3.0%	$2.05B-0.9%	$2.07B
Depreciation and amortization	$1.14B+2.7%	$1.11B-1.0%	$1.13B-0.4%	$1.13B
Restructuring costs	$105.0M+56.7%	$67.0M-20.2%	$84.0M+200.0%	$28.0M
Income from operations	$2.18B-0.9%	$2.20B+11.4%	$1.98B+9.9%	$1.80B
Interest income	-$45.0M+4.3%	-$47.0M-30.6%	-$36.0M-176.9%	-$13.0M
Interest expense	$729.0M+8.8%	$670.0M-0.3%	$672.0M+61.5%	$416.0M
Loss on extinguishment of debt	$6.0M	$0-100.0%	$6.0M	$0
Other income, net	-$99.0M-10.0%	-$90.0M+27.4%	-$124.0M-475.8%	$33.0M
Income before income taxes and equity in earnings of unconsolidated affiliates	$1.59B-4.7%	$1.67B+14.4%	$1.46B+7.0%	$1.36B
Income tax expense	$252.0M-16.3%	$301.0M+198.0%	$101.0M-61.2%	$260.0M
Income before equity in earnings of unconsolidated affiliates	$1.34B-2.1%	$1.37B+0.7%	$1.36B+23.1%	$1.10B
Equity in earnings of unconsolidated affiliates	$22.0M+340.0%	$5.0M	$0+100.0%	-$12.0M
Net income	$1.36B-0.9%	$1.37B+1.1%	$1.36B+24.5%	$1.09B
Net Income (Loss) Attributable to Noncontrolling Interest	-$1.0M	$0	$0	—
Net income	$1.36B-0.9%	$1.37B+1.1%	$1.36B+24.5%	$1.09B
Basic (in dollars per share)	$7910000.00+4.5%	$7570000.00+2.4%	$7390000.00+27.0%	$5820000.00
Diluted (in dollars per share)	$7840000.00+4.7%	$7490000.00+2.7%	$7290000.00+27.4%	$5720000.00
Basic (in shares)	171.9M-5.2%	181.3M-1.4%	183.8M-2.0%	187.6M
Diluted (in shares)	173.5M-5.4%	183.4M-1.6%	186.3M-2.3%	190.6M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.